COMBINATION THERAPY Russian patent published in 2021 - IPC A61K31/52 A61P35/00

Abstract RU 2754507 C2

FIELD: medicine; oncology.

SUBSTANCE: present group of inventions relates to medicine, namely to oncology, and concerns the combination therapy of lymphoma. To do this, phosphatidylinositol 3-kinase duvesilib inhibitor in combination with XP01 selinexor inhibitor or in combination with checkpoint PD-1 inhibitor is injected.

EFFECT: invention provides for the effective treatment of lymphoma due to the synergetic antitumor effect of combination components.

35 cl, 2 ex, 1 tbl, 1 dwg

Similar patents RU2754507C2

Title	Year	Author	Number
NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION	2016	Mehta, Vimal D. Rastelli, Luca Sapra, Aparna Katoch	RU2817047C2
NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION	2016	Mehta, Vimal D. Rastelli, Luca Sapra, Aparna Katoch	RU2711380C2
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT	2016	Sung Dzhon	RU2752506C2
SYNERGISTIC COMBINATIONS OF AURISTANE	2015	Sapra, Puja Shor, Boris	RU2717570C2
COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER	2016	Sung, Dzhon	RU2786570C2
USING BRAF INHIBITORS FOR TREATING SKIN REACTIONS	2017	Shelach, Noa	RU2722667C2
IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS	2017	Cheng, Yung-Chi Chen, Lieping	RU2753523C2
THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY	2011	Khershberg Robert Kukos Dzhordzh Ditsh Gregori Fachchjabene Andrea Mandzharrez Kristi Rendall Tressa D.	RU2603467C2
METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES	2012	Zhen Pinda Martin Majkl Izbester Pol Lejn Bendzhamin S. Kropp Dzhejson	RU2626883C2
METHODS OF TREATMENT	2020	Li, Peng Davis, Robert	RU2822394C1

RU 2 754 507 C2

Authors

Kutok, Jeffery, L.

Dates

2021-09-02—Published

2017-06-23—Filed